뉴스
- Biotech Stocks Rally with Market Rebound; Orum Therapeutics Jumps 18% [K-Bio Pulse] On July 31, South Korean pharmaceutical and biotech stocks broadly advanced as domestic equities rebounded
- Mifegyne Approval Hopes Lift Hyundai Pharm and Daehwa [K-Bio Pulse] South Korea’s pharmaceutical and life sciences sectors broadly declined on July 14.The pharmaceutical
- Diagnostics Rally Despite Kolon TissueGene Trial Shock[K-Bio Pulse] Investor sentiment across South Korea’s pharmaceutical and life sciences sectors remained weak on July 22 following the Phase 3 setback for Kolon TissueGene’s osteoarthritis candidate TG-...
- HLB Hits Limit-Up on FDA Optimism; Curiosis, Peptron Rebound Sharply [K-Bio Pulse] On July 15, South Korean pharmaceutical and biotech stocks rallied, led by a broad surge in HLB affiliates
- Lemon Healthcare's Wild Debut, Vivozon's Clinical Boost [K-bio pulse] On July 6, the pharmaceutical and biotechnology industry saw newly listed Lemon Healthcare experience
- Peptron Sinks on Fading Lilly Hopes; Nature Cell, BL Pharmtech Hit Limit-Up [K-Bio Pulse] On July 9, South Korean pharmaceutical and biotech stocks saw sharply divergent moves, with Nature Cell
- [K-Bio Pulse]Black Friday Hits Korean Biotech South Korea's pharmaceutical and biotech sector suffered broad-based losses on July 3 in what resembled